Mevion Medical wins FDA 510(k) clearance for Mevion S250 proton therapy systems
Littleton, Mass.-based Mevion Medical Systems won FDA clearance for its Mevion S250 system, which the company calls a "1st-of-its-kind" device providing precise, non-invasive proton therapy with higher patient throughput, a reduced footprint, and lower implementation and operational costs.
Toshiba touts FDA OK for VeloCT dose-reducing console
Toshiba Medical Systems (TYO:6502) announced FDA clearance for its next-generation Encore VeloCT console, with upgrades in dose reduction and workflow for the Aquilion 64 and Aquilion CX computed tomography imaging systems.
Allied Healthcare submits CE Mark application for CardioCel patch
Australia-based Allied Healthcare Group submitted a CE Mark application for approval in the European Union of its CardioCel cardiovascular patch for use in cardiac surgical repair.